Shuichi Hironaka

20PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersEpidemiological modellingCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 21, 2026
Early-onset chemotherapy-induced neutropenia and ascites control in patients with severe peritoneal metastasis of gastric cancer: a post hoc analysis of the JCOG1108/WJOG7312G trial.

|Sep 11, 2026
Evolution of Real-World Treatment Patterns over Time in Patients with HER2-Negative Advanced Gastric Cancer: A Retrospective Database Cohort Study from Japan.

|Mar 15, 2026
Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer.

Takeru Wakatsuki, Noriko Yamamoto, Naoki Ishizuka

|Jan 27, 2026
Two cases of metastatic colorectal cancer in which epidermal growth factor receptor gene amplification benefited from panitumumab monotherapy.

Taro Sato, Fumio Nagashima, Naohiro Okano

|May 16, 2025
Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High Advanced Gastric or Esophagogastric Junction Cancer.

Hisato Kawakami, Shigenori Kadowaki, Akitaka Makiyama

|Apr 02, 2025
Systemic therapy for pretreated advanced biliary tract cancer: past developments and recent advances.

Naohiro Okano, Angelo Pirozzi, Oluseyi Abidoye

Pageof 4

Frequent Collaborators

3 joint publications

Narikazu Boku

3 joint publications

Hisato Kawakami

2 joint publications

Kensei Yamaguchi

2 joint publications

Tomohiro Nishina